To confirm the results for CD20+ cells, HCC samples were analyzed by immunohistochemistry for CD79a, another pan-B-cell marker that is expressed throughout B-cell-development from very early precursor cells until maturation into plasma cells [20]. Here, CD79A is linked to hepatocellular carcinoma.